{"title":"主动脉瓣钙化进展预测模型的构建与验证。","authors":"Zhen Guo, Zhenyu Xiong, Chaoguang Xu, Jingjing He, Shaozhao Zhang, Rihua Huang, Menghui Liu, Jiaying Li, Xinxue Liao, Xiaodong Zhuang","doi":"10.5334/gh.1473","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The primary objective of this study is to develop and validate a predictive model assessing the likelihood of disease progression in individuals with aortic valve calcification (AVC).</p><p><strong>Methods: </strong>For the second and third visits, 2,533 patients were followed up. They were randomly assigned to a train set and a validation set at a ratio of 7:3. After employing the Least Absolute Shrinkage and Selection Operator (LASSO) and multiple Cox regression to filter predictors, the selected variables were input into the Cox proportional risk model for model construction. Calibration curve, Consistency Index (C-index), Receiver Operating Characteristic (ROC) curve, and Decision Curve Analysis (DCA) were employed to validate the model. Patients were categorized into low- and high-risk groups based on the model's predicted risk score, and survival analysis was conducted using Kaplan-Meier (K-M) plots. An online platform was used to enhance the clinical utility.</p><p><strong>Results: </strong>The incidence of AVC progression was 9.63%. LASSO-Cox regression analysis identified seven variables significantly correlated with AVC progression. In both the training and validation sets, the Area Under the Curve (AUC) and C-index of the prediction model exceeded 0.8. The calibration curve aligned closely with the diagonal line. Decision Curve Analysis (DCA) underscored the clinical application value of the model. Survival analysis demonstrated a significantly higher progression rate in the high-risk group compared to the low-risk group. The online platform visualized the probability of progression.</p><p><strong>Conclusion: </strong>The developed predictive model has proven reliability and accuracy in forecasting the 2-, 3-, and 4-year progression rates of patients with AVC. It offers a dependable framework for estimating progression and facilitating individualized comprehensive prevention strategies for individuals with AVC.</p>","PeriodicalId":56018,"journal":{"name":"Global Heart","volume":"20 1","pages":"84"},"PeriodicalIF":3.1000,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12466327/pdf/","citationCount":"0","resultStr":"{\"title\":\"Construction and Verification of a Predictive Model for the Progression of Aortic Valve Calcification.\",\"authors\":\"Zhen Guo, Zhenyu Xiong, Chaoguang Xu, Jingjing He, Shaozhao Zhang, Rihua Huang, Menghui Liu, Jiaying Li, Xinxue Liao, Xiaodong Zhuang\",\"doi\":\"10.5334/gh.1473\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The primary objective of this study is to develop and validate a predictive model assessing the likelihood of disease progression in individuals with aortic valve calcification (AVC).</p><p><strong>Methods: </strong>For the second and third visits, 2,533 patients were followed up. They were randomly assigned to a train set and a validation set at a ratio of 7:3. After employing the Least Absolute Shrinkage and Selection Operator (LASSO) and multiple Cox regression to filter predictors, the selected variables were input into the Cox proportional risk model for model construction. Calibration curve, Consistency Index (C-index), Receiver Operating Characteristic (ROC) curve, and Decision Curve Analysis (DCA) were employed to validate the model. Patients were categorized into low- and high-risk groups based on the model's predicted risk score, and survival analysis was conducted using Kaplan-Meier (K-M) plots. An online platform was used to enhance the clinical utility.</p><p><strong>Results: </strong>The incidence of AVC progression was 9.63%. LASSO-Cox regression analysis identified seven variables significantly correlated with AVC progression. In both the training and validation sets, the Area Under the Curve (AUC) and C-index of the prediction model exceeded 0.8. The calibration curve aligned closely with the diagonal line. Decision Curve Analysis (DCA) underscored the clinical application value of the model. Survival analysis demonstrated a significantly higher progression rate in the high-risk group compared to the low-risk group. The online platform visualized the probability of progression.</p><p><strong>Conclusion: </strong>The developed predictive model has proven reliability and accuracy in forecasting the 2-, 3-, and 4-year progression rates of patients with AVC. It offers a dependable framework for estimating progression and facilitating individualized comprehensive prevention strategies for individuals with AVC.</p>\",\"PeriodicalId\":56018,\"journal\":{\"name\":\"Global Heart\",\"volume\":\"20 1\",\"pages\":\"84\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-09-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12466327/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Global Heart\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.5334/gh.1473\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global Heart","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5334/gh.1473","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
摘要
背景:本研究的主要目的是建立并验证一种预测模型,评估主动脉瓣钙化(AVC)患者疾病进展的可能性。方法:对2533例患者进行第二次和第三次随访。他们被随机分配到训练集和验证集,比例为7:3。采用最小绝对收缩和选择算子(LASSO)和多重Cox回归对预测因子进行筛选后,将选择的变量输入到Cox比例风险模型中进行模型构建。采用校准曲线、一致性指数(C-index)、受试者工作特征(ROC)曲线和决策曲线分析(DCA)对模型进行验证。根据模型预测的风险评分将患者分为低危组和高危组,并使用Kaplan-Meier (K-M)图进行生存分析。利用网络平台提高临床应用效果。结果:AVC进展率为9.63%。LASSO-Cox回归分析发现7个变量与AVC进展显著相关。在训练集和验证集,预测模型的曲线下面积(Area Under the Curve, AUC)和C-index均超过0.8。校正曲线与对角线紧密对齐。决策曲线分析(Decision Curve Analysis, DCA)强调了模型的临床应用价值。生存分析显示,与低危组相比,高危组的进展率明显更高。在线平台可视化了进程的概率。结论:所建立的预测模型在预测AVC患者的2年、3年和4年进展率方面具有较高的可靠性和准确性。它提供了一个可靠的框架估计进展和促进个体化的综合预防策略,个人与AVC。
Construction and Verification of a Predictive Model for the Progression of Aortic Valve Calcification.
Background: The primary objective of this study is to develop and validate a predictive model assessing the likelihood of disease progression in individuals with aortic valve calcification (AVC).
Methods: For the second and third visits, 2,533 patients were followed up. They were randomly assigned to a train set and a validation set at a ratio of 7:3. After employing the Least Absolute Shrinkage and Selection Operator (LASSO) and multiple Cox regression to filter predictors, the selected variables were input into the Cox proportional risk model for model construction. Calibration curve, Consistency Index (C-index), Receiver Operating Characteristic (ROC) curve, and Decision Curve Analysis (DCA) were employed to validate the model. Patients were categorized into low- and high-risk groups based on the model's predicted risk score, and survival analysis was conducted using Kaplan-Meier (K-M) plots. An online platform was used to enhance the clinical utility.
Results: The incidence of AVC progression was 9.63%. LASSO-Cox regression analysis identified seven variables significantly correlated with AVC progression. In both the training and validation sets, the Area Under the Curve (AUC) and C-index of the prediction model exceeded 0.8. The calibration curve aligned closely with the diagonal line. Decision Curve Analysis (DCA) underscored the clinical application value of the model. Survival analysis demonstrated a significantly higher progression rate in the high-risk group compared to the low-risk group. The online platform visualized the probability of progression.
Conclusion: The developed predictive model has proven reliability and accuracy in forecasting the 2-, 3-, and 4-year progression rates of patients with AVC. It offers a dependable framework for estimating progression and facilitating individualized comprehensive prevention strategies for individuals with AVC.
Global HeartMedicine-Cardiology and Cardiovascular Medicine
CiteScore
5.70
自引率
5.40%
发文量
77
审稿时长
5 weeks
期刊介绍:
Global Heart offers a forum for dialogue and education on research, developments, trends, solutions and public health programs related to the prevention and control of cardiovascular diseases (CVDs) worldwide, with a special focus on low- and middle-income countries (LMICs). Manuscripts should address not only the extent or epidemiology of the problem, but also describe interventions to effectively control and prevent CVDs and the underlying factors. The emphasis should be on approaches applicable in settings with limited resources.
Economic evaluations of successful interventions are particularly welcome. We will also consider negative findings if important. While reports of hospital or clinic-based treatments are not excluded, particularly if they have broad implications for cost-effective disease control or prevention, we give priority to papers addressing community-based activities. We encourage submissions on cardiovascular surveillance and health policies, professional education, ethical issues and technological innovations related to prevention.
Global Heart is particularly interested in publishing data from updated national or regional demographic health surveys, World Health Organization or Global Burden of Disease data, large clinical disease databases or registries. Systematic reviews or meta-analyses on globally relevant topics are welcome. We will also consider clinical research that has special relevance to LMICs, e.g. using validated instruments to assess health-related quality-of-life in patients from LMICs, innovative diagnostic-therapeutic applications, real-world effectiveness clinical trials, research methods (innovative methodologic papers, with emphasis on low-cost research methods or novel application of methods in low resource settings), and papers pertaining to cardiovascular health promotion and policy (quantitative evaluation of health programs.